Xilong Scientific News

Xilong Science (002584) review: Plans to invest in Iqway's healthcare sector layout further

華創證券Dec 15, 2017 00:00

Xilong Science (002584) In-depth research: leading domestic chemical reagents lay out medical and “Internet +” fields

海通證券Sep 22, 2017 00:00

Comments on Xilong Science (002584): the new production capacity of reagents is gradually released and the gene testing business rises abruptly based on its accumulated strength.

國泰君安Aug 25, 2017 00:00

Xilong Science (002584) comments: extension of in vitro diagnosis industry chain of the largest local chemical reagent supplier in China

海通證券Jun 13, 2017 00:00

[Guoyuan Securities] Xilong Science: layout gene sequencing, plus in vitro diagnosis

國元證券May 25, 2016 00:00

Comments on Xilong Science (002584): layout gene sequencing plus in vitro diagnosis

國元證券May 25, 2016 00:00

Xilong Science (002584) comments: medical business will break out traditional business to explore e-commerce model

國元證券May 19, 2016 00:00

Xilong Science (002584): the first quarter results are in line with the expected distribution of in vitro diagnostic reagents.

太平洋證券Apr 26, 2016 00:00

Xilong Science (002584) in-depth Research: Mao Chemical Reagent Business steadily and steadily in Medical Health Business

華創證券Apr 6, 2016 00:00

Comments on Xilong Science (002584) Annual report: 16 years of high growth is expected to continue to promote strategic transformation

華泰證券Mar 25, 2016 00:00

【华泰证券】西陇科学:16年高增长有望,战略转型继续推进

華泰證券Mar 24, 2016 00:00

西陇科学(002584)事件点评：布局基因测序 成长空间广阔

國海證券Mar 16, 2016 00:00

【国海证券】西陇科学事件点评:布局基因测序,成长空间广阔

國海證券Mar 15, 2016 00:00

西陇科学(002584)点评：投资FULGENT 进军基因检测领域

華泰證券Mar 15, 2016 00:00

西陇科学(002584)点评：投资海外基因检测公司 完善体外诊断试剂产业链布局

安信證券Mar 15, 2016 00:00

【安信证券】西陇科学:投资海外基因检测公司,完善体外诊断试剂产业链布局

安信證券Mar 15, 2016 00:00

【华泰证券】西陇科学:投资Fulgent,进军基因检测领域

華泰證券Mar 14, 2016 00:00

西陇科学(002584)：外延并购加速进军体外诊断领域

太平洋證券Mar 14, 2016 00:00

西陇科学(002584)点评：引入亚东投资 助推电商平台发展

華泰證券Mar 11, 2016 00:00

【华泰证券】西陇科学:引入亚东投资,助推电商平台发展

華泰證券Mar 10, 2016 00:00